MedPath

Effects of PEP on IC During IT in Patients With COPD

Not Applicable
Terminated
Conditions
Chronic Obstructive Pulmonary Disease
Registration Number
NCT03657082
Lead Sponsor
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Brief Summary

This study will investigate the effects of positive expiratory pressure (PEP) on hyperinflation in patients with chronic obstructive pulmonary disease (COPD). Inspiratory capacity (IC) is the primary outcome

Detailed Description

This is a cross-over intervention assessing the effect of PEP on IC and dyspnea in patients with COPD performing an interval training (IT) session.

IC will be measured before, during and immediately after the IT session. Each participant will receive perform IT sessions including either the use of a PEP of 10 cmH2O or a PEP of 1 cmH2O. The effects on IC and dyspnea on both PEP levels will be assessed.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
1
Inclusion Criteria
  • Stable COPD since 1 month at least
  • Able to understand the instructions
Exclusion Criteria
  • COPD with a forced expiratory volume at one second > 80% of predicted values
  • In exacerbation
  • Orthopedic of neurological condition likely to interfere with the experimentation
  • Contraindication to perform exercise

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Change in inspiratory capacity20 minutes

Evolution of inspiratory capacity while performing the interval training session

Secondary Outcome Measures
NameTimeMethod
Change in Borg scale20 minutes

Evolution of dyspnea while performing the interval training session

Trial Locations

Locations (1)

Cliniques universitaires Saint-Luc

🇧🇪

Brussels, Belgium

Cliniques universitaires Saint-Luc
🇧🇪Brussels, Belgium

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.